Medication error when switching from warfarin to rivaroxaban leading to spontaneous large ecchymosis of the abdominal and chest wall

Medication error when switching from warfarin to rivaroxaban leading to spontaneous large ecchymosis of the abdominal and chest wall

Non-vitamin K oral anticoagulant (NOAC) therapy may be inappropriate if prescription was incorrect, the patient’s physiological parameters change, or interacting concomitant medications are erroneously added. The aim of this report was to illustrate inappropriate NOAC prescription in a 78-year-old w...

Полное описание

Библиографические подробности
Главные авторы:	Flavio Egger, Federica Targa, Ivan Unterholzner, Russell P. Grant, Markus Herrmann, Christian J. Wiedermann
Формат:	Статья
Язык:	English
Опубликовано:	MDPI AG 2016-08-01
Серии:	Clinics and Practice
Предметы:	Direct oral anticoagulants therapeutic drug monitoring drug safety drug-drug interaction pharmacovigilance anticoagulant reversal
Online-ссылка:	https://www.clinicsandpractice.org/index.php/cp/article/view/873

Схожие документы

Warfarin interactions: a letter to editor
по: Sayyed Majid Sadrzadeh, и др.
Опубликовано: (2019-10-01)

Case report: Medical cannabis—warfarin drug-drug interaction
по: Tyan F. Thomas, и др.
Опубликовано: (2022-01-01)

A rare case of Diffuse Alveolar Hemorrhage (DAH) due to warfarin toxicity
по: Borjian Solmaz, и др.
Опубликовано: (2020-03-01)

Advances in Monitoring and Reversal Strategies for the Novel Anticoagulants Factor Ⅺ Inhibitors
по: CHEN Yuexiu, YAO Yuanyuan, SUN Dawei, WANG Ying, WU Chaomin, ZHAO Linqian, TANG Zhifeng, ZHANG Fengjiang
Опубликовано: (2025-01-01)

Warfarin-Induced Limb Contusion and Haematoma
по: Soumya, и др.
Опубликовано: (2023-04-01)

Warfarin: pharmacological profile and drug interactions with antidepressants
по: Juliana Souto Teles, и др.
Опубликовано: (2012-03-01)

Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
по: N. T. Vatutin, и др.
Опубликовано: (2020-03-01)

Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
по: Yuri B. G. Patriota, и др.
Опубликовано: (2021-05-01)

Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report
по: Gumbis G, и др.
Опубликовано: (2023-10-01)

Possible interaction of warfarin with peppermint herbal tea: a case report
по: Aliasghar Moeinipour, и др.
Опубликовано: (2017-05-01)

The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
по: Salih Kılıç, и др.
Опубликовано: (2019-01-01)

Anticoagulation Drug Therapy: A Review
по: Harter, Katherine, и др.
Опубликовано: (2015-01-01)

Warfarin: pharmacological profile and drug interactions with antidepressants
по: Juliana Souto Teles, и др.
Опубликовано: (2012-03-01)

Effects of sodium ferulate for injection on anticoagulation of warfarin in rats in vivo
по: Yue Zhao, и др.
Опубликовано: (2024-02-01)

Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications
по: T. Jared Bunch, и др.
Опубликовано: (2016-07-01)

Research progress of antithrombotic drugs
по: ZHANG Jie, MA Xuzhou, LI Huihui, WANG Miao
Опубликовано: (2023-01-01)

Assessing the link between rivaroxaban concentration and the onset of renal impairment in elderly patients: A retrospective observational study
по: Motakatla Usha Rani, и др.
Опубликовано: (2024-06-01)

An Assessment of Osteoporotic Conditions among Users and Non-Users of Warfarin: A Case-Control Study
по: Aseel Hadi Abdulameer, и др.
Опубликовано: (2017-03-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
по: O. V. Shatalova, и др.
Опубликовано: (2015-09-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
по: O. V. Shatalova, и др.
Опубликовано: (2015-09-01)

Idiosyncratic Liver Injury due to Rivaroxaban
по: Aneesh Cherakulam Ratheendran, и др.
Опубликовано: (2017-12-01)

Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System
по: Ana Sofia Martins, и др.
Опубликовано: (2024-10-01)

Profile and outcome of patients with Warfarin Toxicity admitted in a tertiary care hospital in Bhutan: a cross-sectional study investigators and institutions
по: Yeshey Penjore, и др.
Опубликовано: (2023-05-01)

Massive spontaneous subconjunctival hemorrhage in a patient on therapeutic warfarin: A case report
по: Andrew M. Philip, и др.
Опубликовано: (2021-06-01)

Farmacovigilância: um instrumento necessário
по: Helena Lutéscia Coêlho

Bleeding complications following intramuscular injections among hospitalized anticoagulated patients: a retrospective observational comparative study
по: Marina Davidov, и др.
Опубликовано: (2024-10-01)

Apixaban dosing in hemodialysis - can drug level monitoring mitigate controversies?
по: Simeon Schietzel, и др.
Опубликовано: (2024-10-01)

Assessment of prescribing pattern and adverse drug reaction in patients receiving anticoagulant therapy: A prospective observational study
по: Thangavel Mahalingam Vijayakumar, и др.
Опубликовано: (2023-08-01)

Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
по: Ki Won Hwang, и др.
Опубликовано: (2023-04-01)

Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study
по: Takafumi Yuki, MD, PhD, и др.
Опубликовано: (2017-01-01)

Interaction between Levothyroxine and Phenprocoumon: a case report
по: Gaeti Walderez, и др.
Опубликовано: (2014-04-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
по: S. K. Zyryanov, и др.
Опубликовано: (2020-05-01)

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
по: Brandon K. Martinez, и др.
Опубликовано: (2018-04-01)

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
по: Anne-Laure Sennesael, и др.
Опубликовано: (2018-11-01)

Advancing anticoagulation stewardship: A call to action for stewardship from the US-based anticoagulation forum
по: Allison Burnett, и др.
Опубликовано: (2022-12-01)

Potential drug-drug interactions among patients with spontaneous intracerebral hemorrhage treated at the Neurological Intensive Care Unit: a single-center experience
по: Dejan Z. Aleksić, и др.
Опубликовано: (2022-11-01)

Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017
по: Josipa Bukic, и др.
Опубликовано: (2019-10-01)

Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia–reperfusion injury
по: Sinan Demirtas, и др.
Опубликовано: (2015-03-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
по: Alan O. Vázquez-Alvarez, и др.
Опубликовано: (2017-12-01)

Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting
по: Abel Tenaw Tasamma, и др.
Опубликовано: (2025-01-01)